Key result
Wearable 12-lead ECG identifies occlusive MI comparably to standard ECG.
Why the study?
Conventional 12-lead ECG requires specialized equipment that may delay diagnosis in patients with acute chest pain. Wearable 12-lead ECG devices offer a more accessible alternative, but their diagnostic accuracy for detecting ST-segment deviations and occlusive myocardial infarction remained inadequately validated.
Does a wearable 12-lead ECG provide comparable diagnostic accuracy to a conventional 12-lead ECG for detecting ST-segment deviations and occlusive myocardial infarction in patients presenting with acute chest pain?
Observational (n=503)
Assessor-blinded (two senior cardiologists blinded to clinical and angiographic outcomes)
No
Does a wearable 12-lead ECG provide comparable diagnostic accuracy to a conventional 12-lead ECG for detecting ST-segment deviations and occlusive myocardial infarction in patients presenting with acute chest pain?
A wearable 12-lead ECG provides high diagnostic accuracy for detecting ST-segment deviations and performs comparably to a standard 12-lead ECG in identifying occlusive myocardial infarction and culprit vessels in acute chest pain.
Supports wearable ECG feasibility for ST-deviation assessment in chest pain; leaves open whether it improves outcomes or workflow before clinical adoption.
Background Timely and accurate identification of myocardial ischemia is critical for improving outcomes in patients with acute chest pain. Although the conventional 12-lead electrocardiogram (ECG) is the standard for detecting ST-segment changes, its dependence on specialized equipment may delay diagnosis. Wearable ECG devices offer a more accessible alternative, but their diagnostic accuracy remains inadequately validated. Purpose To assess the diagnostic accuracy of a wearable 12-lead ECG in detecting ST-segment deviations and occlusive myocardial infarction (OMI) in patients presenting with chest pain. Methods This prospective study enrolled patients presenting with acute chest pain to the emergency department of a tertiary hospital between May 2025 and January 2026. Both conventional and wearable 12-lead ECGs were recorded prior to coronary intervention. Two senior cardiologists, blinded to clinical and angiographic outcomes, independently interpreted all ECGs. OMI was defined as a culprit lesion with Thrombolysis in Myocardial Infarction (TIMI) flow grade 0–2 or TIMI flow grade 3 accompanied by a peak high-sensitivity troponin T level of >1000 ng/L. Results A total of 503 patients were enrolled (mean age 66.4±15.1 years; 66.7% male). Using the conventional 12-lead ECG as the reference standard, the wearable ECG demonstrated high diagnostic accuracy for ST-segment elevation (sensitivity 92.7%, specificity 99.4%) and depression (sensitivity 91.8%, specificity 98.9%). Among 57 patients with confirmed OMI, the wearable ECG showed comparable sensitivity (75.4% vs 78.9%, P=0.48) and specificity (91.2% vs 89.7%, P=0.56) to the conventional 12-lead ECG. The accuracy of culprit vessel identification by ECG was also similar between the two modalities (63.2% vs 66.7%, P=0.52). Conclusions The wearable 12-lead ECG provides high diagnostic accuracy for detecting ST-segment deviations and performs comparably to the standard 12-lead ECG in identifying OMI and localizing the culprit vessel, supporting its potential as a reliable and accessible tool for early triage in acute chest pain.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) conducted an observational in Acute chest pain / suspected acute myocardial ischemia (n=503). Wearable 12-lead ECG vs. Conventional 12-lead ECG was evaluated on Sensitivity for detecting occlusive myocardial infarction (OMI) (p=0.48). Wearable 12-lead ECG detected ST-elevation with 92.7% sensitivity/99.4% specificity and identified occlusive MI comparably to standard ECG (sensitivity 75.4% vs 78.9%, P=0.48).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: